Business Context and Reporting Period
This Form 6-K filing by InterContinental Hotels Group PLC covers the period ending March 6, 2026. The report primarily discloses regulatory notifications regarding Persons Discharging Managerial Responsibilities (PDMRs) shareholdings, transactions in own shares (share buybacks), and updates to total voting rights. The company operates under the authority granted by shareholders at the Annual General Meeting on May 8, 2025.
Key Financial Metrics and Capital Structure
The filing does not contain revenue, profit, cash flow, or margin data. However, it provides specific details on capital structure and share repurchase activity:
- Shares in Issue: As of March 5, 2026, the company has 150,700,048 ordinary shares in issue.
- Treasury Shares: The company holds 5,481,782 shares in treasury.
- Total Voting Rights: As of February 28, 2026, total voting rights were 150,950,048.
- Share Buyback Activity: Between February 20 and March 5, 2026, the company purchased a total of 554,849 ordinary shares on the London Stock Exchange via Goldman Sachs International.
- Buyback Price Range: The average price paid per share during this period ranged from approximately $128.95 to $143.26, with the lowest single transaction price at $126.80 and the highest at $145.00.
Material Changes and Transactions
Significant changes in the reporting period include:
- Reduction in Share Count: The company actively reduced its share count through daily buybacks, intending to cancel all purchased shares. The issued share count decreased from approximately 151.19 million on February 20 to 150.70 million on March 5.
- Executive Share Vesting and Sales:
- February 18, 2026: Shares vested under the 2023/25 Deferred Award Plan for multiple executives (including CEO Elie Maalouf and CFO Michael Glover). Several executives (Heather Balsley, Yasmin Diamond, Nicolette Henfrey, Kenneth Macpherson) sold their entire vested allotment immediately upon vesting at approximately $144.34 per share.
- February 27, 2026: Shares vested under the 2022 Annual Performance Plan. Three executives sold their vested shares at approximately $138.69 per share.
- March 4, 2026: Jolie Fleming (Chief Product & Technology Officer) disposed of 4,608 shares at $135.00 per share.
- New Share Grants: On March 3, 2026, forfeitable share awards were granted to PDMRs under the Deferred Award Plan. These awards were calculated based on a share price of $143.15 (MMQ of the three business days following the FY2025 results announcement).
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on operational outlook, or specific risk factors. The document is strictly a compliance filing under the Market Abuse Regulation (Article 19) and Disclosure and Transparency Rules. The only forward-looking element is the vesting schedule for new awards granted on March 3, 2026, which are conditional on continued employment until February 28, 2029, and the satisfaction of performance conditions tied to future financial year results.
Investor Verification Checklist
- Share Count Accuracy: Verify the updated share count of 150,700,048 in subsequent filings to confirm the cancellation of repurchased shares.
- Executive Retention: Monitor whether executives who sold 100% of their vested shares (e.g., Heather Balsley, Kenneth Macpherson) retain any other significant holdings or if this indicates a change in sentiment.
- Buyback Program Status: Confirm if the company continues the buyback program initiated on February 17, 2026, and the remaining authority under the May 2025 AGM resolution.
- Valuation Benchmark: Note the reference price of $143.15 used for new executive grants, which reflects the market valuation immediately following the FY2025 results announcement.